Protein Kinase C Inhibitors as Modulators of Vascular Function and Their Application in Vascular Disease

Pharmaceuticals - Switzerland
doi 10.3390/ph6030407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

The Proliferative Effect of Vascular Endothelial Growth Factor Requires Protein Kinase C- And Protein Kinase C-

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1999English

Prevention of Vascular Nitroglycerin Tolerance by Inhibition of Protein Kinase C

British Journal of Pharmacology
Pharmacology
1996English

Activation of Vascular Protein Kinase C- Inhibits Akt-Dependent Endothelial Nitric Oxide Synthase Function in Obesity-Associated Insulin Resistance

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Overview: Pulmonary Vascular Function in Health and Disease

Journal of Physiology
PhysiologySports Science
2019English

Function, Role, and Clinical Application of MicroRNAs in Vascular Aging

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Novel Protein Kinase Targets in Vascular Smooth Muscle Therapeutics

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2017English

Elastase and Matrix Metalloproteinase Inhibitors Induce Regression, and Tenascin-C Antisense Prevents Progression, of Vascular Disease

Journal of Clinical Investigation
Medicine
2000English

Role of ACE Inhibitors in Hypertension Complicated by Vascular Disease

Heart
Cardiovascular MedicineCardiology
1994English

In VivoEffects of Antiviral Protein Kinase C Modulators on Zebrafish Development and Survival

ISRN Toxicology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy